Intra-tumor heterogeneity (ITH) encompasses cellular differences in tumors and is related to clinical 34 outcomes, such as drug resistance. However, little is known about the dynamics of ITH, owing to the lack 35 of time-series analysis at the single-cell level. We performed single-cell exome and transcriptome 36 sequencing of 200 cells and investigated how ITH is generated from one single cell in a mouse colorectal 37 cancer model. The ITH of the transcriptome increased after transplantation from cultured organoids, while 38 that of the exome decreased. Mutations generated in the culture did not greatly change at the 39 transplantation at the bulk-cell level. The RNA ITH increase was due to the emergence of new 40 transcriptional subpopulations. In contrast to the initial cells expressing mesenchymal-marker genes, new 41 subpopulations repressed these genes at transplantation. Analyses of colorectal cancer data from The 42 Cancer Genome Atlas revealed a high proportion of metastatic cases in human subjects with expression 43 patterns similar to the new cell subpopulations in mouse. These results suggest that the birth of 44 transcriptional subpopulations may be a key for adaptation to drastic micro-environmental changes when 45 cancer cells have sufficient genetic alterations at later tumor stages. This study revealed an evolutionary 46 dynamics of single-cell RNA and DNA changes in tumor progression, giving insights into the 47 mesenchymal-epithelial transformation of tumor cells at metastasis in colorectal cancer. 48 49 50 Keywords 51 Single-cell sequencing, cancer genomics, colorectal cancer, tumorigenesis, intra-tumor heterogeneity 52 53 54 4 Background 55 It is well established that cancer is pathologically composed of different types of cells [1]; however, intra-56 tumor heterogeneity (ITH) has only been recently addressed at the genomic level [2]. ITH is clinically 57 important. For example, elevated copy-number heterogeneity is related to an increased risk of recurrence 58 or death in non-small-cell lung cancer [3]. High levels of ITH ultimately provide the seeds for the 59 emergence of anti-cancer drug resistance [4]. High levels of genetically-characterized heterogeneity in 60 Barrett's esophagus are associated with incidence of esophageal adenocarcinoma [5]. 61 ITH essentially stands for the cellular differences in tumor tissue arising from genetic changes, 62 called clonal evolution, or non-genetic changes, such as cancer stem cells and simple transcriptional 63 responses to the environment. In clonal evolution, as in Darwinian evolution, cancer cells with 64 advantageous genetic mutations evolve into different types of cancer cells [6]. In contrast, cancer stem 65 cells, like normal stem cells, produce a variety of differentiated daughter cells that constitute 66 phenotypically distinct cancer cells without genetic differences through epigenetic and the resultant 67 transcriptional mechanisms [7, 8].
associated with positive regulation of cGMP and guanylate cyclase (GC) activity (referred to as cGMP/GC 149 genes) (P = 1.30 × 10 −3 ), which are known to be associated with negative regulation of -catenin signaling 150 and matrix metalloproteinase activity in colorectal cancer [27, 28] . 151 A heatmap generated from the cluster analysis revealed that T1 cells were relatively homogenous 152 and formed one group that highly expressed Anti-Epithelial genes but showed negligible expression of 153 cGMP/GC genes (Fig. 2C) . This group was therefore termed Anti-Epithelial. In addition to an Anti- 154 Epithelial cell group, two new groups appeared at T2: one showing the opposite pattern, repression of 155 Anti-Epithelial and activation of cGMP/GC gene expression, referred to as the cGMP/GC cell group; the 156 other showed repression of both Anti-Epithelial and cGMP/GC genes, referred to as the Dormant group 157 for the marker analysis described below. Notably, as shown in the heat map, bulk-cell sequencing analysis 158 alone could not have identified these cell groups, where their distinct expression patterns were offset by 159 bulk-cell expression levels (labeled as T1, T2, and T3 bulk in Fig. 2C ). 160 Using a PCA plot based on highly variable gene expression, we confirmed that T1 cells were 161 relatively homogeneous and T2 cells showed similar grouping to T3 cells (Fig. 2D) . Looking at the PCA 162 closer, we found that cells of the Anti-Epithelial group seemed close together across all time points, but 163 seemed to form two groups-i.e., T1 main (referred to as T1 main) and T1/T2/T3 mixture (T1+T2+T3). 164 The cGMP/GC and Dormant groups seemed close together and contained T2 and T3 only (T2+T3 only).
166
Marker gene expression 167 We examined the expression of several types of marker genes. We first looked at proliferation/cell cycle 168 markers (Additional file 1: Figure S5 ) and performed PCA to summarize the multiple expression levels 169 (Fig. 3A) . Remarkably, most cells in the Anti-Epithelial group at T1 expressed high levels of proliferation-170 and cell cycle-related genes according to the PCA loading plot. In contrast, nearly all cells in the Dormant 171 group at T3 showed a downregulation of the marker genes (so the cell group was termed Dormant). At T2, 172 about half of the cells showed a downregulation of the proliferation/cell-cycle genes. 173 We next examined epithelial and mesenchymal markers (Additional file 1: Figure S5) . A PCA 174 plot of the markers showed that expression of mesenchymal cell-related genes decreased with time (T2 175 9 and T3), with cells forming two groups ( Fig. 3B) : one (upper left) overlapping with some T1 Anti- 176 Epithelial cells with decreased mesenchymal N-cadherin (CDH2) and fibronectin (FN1) levels; the other 177 (middle right) group was composed only of T3 cells with decreased mesenchymal vimentin (VIM) and 178 increased epithelial E-cadherin (CDH1) levels. These results suggest a similarity between the processes 179 occurring from T1 to T2 and mesenchymal-epithelial transition (MET).
180
Stem cell and differentiation markers showed that over time, cells generally expressed more 181 differentiation than stem cell markers ( Fig. 3C ; Additional file 1: Figure S5 ), though a remarkable 182 variation across individual cells was also observed. Fractions of cells with the expressions of stem cell 183 markers decreased with time. Among the markers for crypt base stem cells, SOX9 appeared to be the most 184 influential;
LGR5, OLFM4, and MSI1 were not substantially expressed. It seems that with time, cells 185 differentiated into those expressing a marker for absorption cells (KRT20) and those for secretion cells 186 (MUC2) in the digestive tract.
187
There was no remarkable change in the expression of drug efflux genes [29, 30] the bulk-cell sequencing; in theory, the single-cell fractions should be equal to half of the VAFs. We 203 confirmed a good concordance between these variables, although the cell fractions were slightly lower 204 than those expected from bulk VAFs (Additional file 1: Figure S6 ). 205 We first examined the bulk-cell sequence data. The T0.5 tissue had much fewer SNVs than the 206 later stages (Fig. 4A) , which suggests that DNA heterogeneity only weakly appeared soon (1.5 months) 207 after culture initiation. The numbers of SNVs increased markedly from T0.5 to T1, a five-month period 208 ( Fig. 4A ). Although these numbers decreased slightly at T2 before recovering at T3, they were all mostly 209 saturated at T1, T2, and T3. Thus, new SNVs were largely generated from T0.5 to T1, and most of these 210 SNVs remained in the genome after T1 at the bulk-cell level (Fig. 4B) . 211 We then used single-cell sequencing data to draw a multi-dimensional scaling (MDS) plot based 212 on single-cell SNVs at polymorphic SNV sites (defined as SNVs with 10-35% bulk VAFs) ( Fig. 4C ). T1 213 cells showed the greatest genetic diversity, whereas T2 and T3 cells showed less diversity. This decrease in 214 diversity was confirmed by a statistical significance of the diversity index (average distance from the 215 centroid), where the bias due to ADO rates was taken into account by a bootstrapping test ( Fig. 4D) . 216 Interestingly, this diversity tendency was the complete opposite of the transcriptomic pattern ( Fig. 2A, B) . 217 Although transitional, cells can be classified into three groups composed of T1 cells only (T1 main); T1, 218 T2, and T3 cells (T1+T2+T3); and T2 and T3 cells (T2+T3 only) ( Fig. 4C) , which could correspond to the 219 three groups in the single-cell transcriptome analysis ( Fig. 2D ) 220 
221
Association with human cancer 222 We used 244 TCGA samples of colorectal cancer [24] to identify human samples with gene 223 expression patterns similar to the groups of mouse single cells by MDS ( Fig. 5A) . In the MDS plot, the 224 human samples were separated from the mouse cell groups, but we found that 94 (38.5%), 42 (17.2%), 225 and 13 (5.3%) human samples were respectively close to the Anti-Epithelial, cGMP/GC, and Dormant samples tended to be more closely associated with metastasis than those with patterns similar to the Anti- Classically, cells that generate a tumor by subcutaneous transplantation are called tumor-initiating 253 cells or cancer stem cells (CSCs) [30] . In this classical model, it is expected that differentiated cells die 254 while CSCs can survive at the start of subcutaneous transplantation and 3D culture; then, CSCs re-255 generate differentiated cells. We initially expected that fractions of cells expressing stem cell markers 256 increased over the serial transplantation, because we simply thought that it is CSCs, not differentiated 257 cells, that can survive at transplantation. However, our observation was the opposite. CSCs that efficiently 258 generate differentiated cells may be more adaptive for the merit of obtaining mutual benefits between 259 different types of cells. Alternatively, contrary to the classical expectations, CSCs may not necessarily 260 express high levels of stem cell markers: the Dormant and cGMP/GC cells with low expression levels of 261 13 stem cell markers may be also CSCs or tumor-initiating cells that survived at the transplantation and 3D 262 culturing.
263
Recently, more fine-scale single-cell sequencing technology, such as 10X/Drop-Seq, has emerged 264 for RNA-seq, enabling researchers to capture tens of thousands of cells. Although the number of cells we 265 addressed was relatively small compared to that technology, we believe that we successfully captured a 266 major part of the heterogeneity constructed by cell clones, constituting as small as ~2% (an inverse 267 number of 42, 42, and 51 cells at T1, T2, and T3) of the tumor cell population. Nevertheless, 10X/Drop-268 Seq will be needed to investigate rarer cells. 269 We demonstrated that time-series ITH analysis by single-cell DNA and RNA sequencing for a Bulk-cell transcriptome and exome sequencing 326 Among the cells that were not used for single-cell capture with the C1 system, suspensions of about 200 327 cells were subjected to whole transcriptome (RNA) sequencing for bulk-cell RNA-seq (T1, T2, and T3 328 samples). The sequencing libraries were prepared using the same reagents as the single cell RNA-seq. As 329 control bulk cells, normal intestinal crypt epithelial cells from two wild-type mice of the same strain were 330 grown in the 3D culture system for seven days, then harvested and lysed for total RNA preparation using 331 the miRNAeasy Mini kit (Qiagen, 217004). RNA-seq libraries for control bulk RNA were generated using 332 the SureSelect Strand-specific kit (Agilent Technologies, G9691B). Bulk DNA from over 1 × 10 5 cells was 333 obtained from the cell culture (T0.5 sample, 1.5 months after culture initiation) and the remaining cells in 
Transcripts per kilobase million (TPM) calculation for single and bulk cells 343
The procedure for calculating TPM is summarized in Additional file 1: Figure S9 . Specifically, sequence 344 reads were quality-filtered and trimmed using PrinSeq [33] , and then used as input for quality-check by 345 FastQC (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/). We used the following parameters: 358 To detect genes with variable expression levels across cells, we defined highly variable genes according to 359 the CV, corrected in the locally weighted scatterplot smoothing (LOWESS) method using the "lowess" For hierarchal clustering, we used the "hclust" function in the "stats" package of R software, where we 379 calculated the Euclidean distance of expression levels (log2 [TPM +1]) of all highly variable genes 380 between cells and used the Ward method for agglomeration. We generated correlation plots of highly 381 variable genes using the "corrplot" function in the R "corrplot" package, where we used the Ward method 382 for agglomeration. We divided genes into three clusters based on these hierarchical clustering results using 383 the "addrect = 3" option. A heatmap was generated using the "heatmap.2" function in the "ggplot2" 384 package. In the heatmap, cells were arranged according to their order in the dendrogram described above 385 and genes were arranged according to their order in the correlation plot of highly variable genes. 
Detection of highly variable genes

399
Variants for which allele frequencies were significantly greater than 1% in the binomial test were retained.
400
The procedure is summarized in Additional file 1: Figure S9 . 401 For single-cell sequencing data, we called SNVs only at SNV sites called in bulk-cell sequencing 402 data. Specifically, we counted nucleotide bases with high qualities (mapQ ≥ 20, BaseQ ≥ 10) in single-cell 403 sequencing data as well as in background data (same as those used in bulk-cell SNV calling) with the 404 Samtools mpileup function [43, 44] . We then selected variants with the largest χ 2 test statistic (with Yates's 405 correction) among all possible variants at each position to identify those that were most likely to differ 406 between single-cell and background data. We required a variant count ≥ 2 and VAF ≥ 2% for such variants 407 in single-cell data. We then selected variants that overlapped with SNV sites called in bulk-cell data. Detecting mutation in cancer-related genes 410 We investigated nonsynonymous mutations in cancer-related genes contained in Tier1 in COSMIC Cancer 414 We performed MDS from the cell × site matrix composed of zero and one, which respectively represent 415 the absence and presence of SNVs (both synonymous and non-synonymous SNVs) and NA, which 416 represents an undetermined call due to shallow depth. We assigned zero to non-called sites as the true 417 negative when those sites had depths  30 and assigned NA to non-called sites when the depth was < 30. 418 We only used SNV sites where a variant was called in at least one cell and the VAFs at the same sites in 419 bulk data ranged from 10-35% (polymorphic) for at least one time point. We removed cells and sites (two 420 each) with too few or too many NAs, yielding 104 sites and 69 cells. Using this 0/1/NA matrix, we 421 calculated the p-distance (proportion of different sites) used in molecular evolution without using NA, and 422 then performed MDS.
MDS of DNA data and the diversity index
423
The diversity index was calculated as the average Euclidian distance from the centroid over cells 424 in the MDS space, where we used up to the sixth dimension because of a sudden drop in the eigenvalues 425 over this dimension. To calculate the statistical significance of differences between cell groups, we used a 426 bootstrapping approach in which we randomly re-sampled cells' sequences from the 0/1/NA matrix of 427 each cell group 10,000 times and performed the same MDS as in the observed data for each replicate. We 428 then calculated the diversity index for each replicate to determine the 95% confidence interval and 429 standard deviation for each cell group. The ADO rate was defined as the rate of homozygous sites in single-cell samples where the bulk sample 439 was heterozygous (defined as sites where VAFs were 45-55%) at the same nucleotide site. We removed 440 outlier cells with high ADO rates at each time point (one cell each with an ADO rate > 80% at T2 and T3).
442
Average copy number 443 The average copy number (ACN) was calculated as follows: sided Kruskal-Wallis test with P values of 5.00  10 -5 and 1.00  10 −9 yielding 171 and 78 variables for 457 histological type and MSI status, respectively. These were used to train a Random Forest classifier with 458 the "randomForest" function in the "randomForest" package of R software, with the options ntree = 10000 459 (setting the number of trees to grow to 1000) and mtry = 5 (setting the number of variables randomly 460 sampled to five). Using the created classifier, the same explanatory variables for mouse data were used to 461 classify each feature in the mouse model. MDS of mouse cell and TCGA samples 463 We first identified TCGA samples with gene expression patterns similar to the mouse single-cell groups.
464
For that purpose, we calculated a normalized 1-r distance as follows: TCGA sample for those whose minimum distance across the groups was less than 4.05 and the difference 472 between the first and second minimum distances was larger than 0.31. For selected TCGA and all mouse 473 single-cell samples, MDS was performed based on the distance of 1-r. 
